Dr Salim Janmohamed, Consultant Physician Specialising in Endocrinology and Diabetes

Dr Salim Janmohamed

Consultant Physician Specialising in Endocrinology and Diabetes

Book online
|

Dr Salim Janmohamed BSC (PHARMACOL) MBBS (TRIPLE HONOURS) FRCP FACE FRSM

Consultant Physician Specialising in Endocrinology and Diabetes

BSC (PHARMACOL) MBBS (TRIPLE HONOURS) FRCP FACE FRSM

Dr Salim Janmohamed

Consultant Physician Specialising in Endocrinology and Diabetes BSC (PHARMACOL) MBBS (TRIPLE HONOURS) FRCP FACE FRSM

BSC (PHARMACOL) MBBS (TRIPLE HONOURS) FRCP FACE FRSM
HCA-Healthcare-UK

Areas of expertise

  • Endocrinology - general, thyroid, weight gain, adrenal, pituitary, pancreas, sex / reproductive hormones
  • Diabetes - medication, glucose control, risk management
  • General (Internal) Medicine
  • Clinical research / trials
HCA-Healthcare-UK

Recommendations for Dr Janmohamed

These recommendations are for information purposes only. Doctors providing recommendations do so in good faith and are not responsible for clinical outcomes.

Address

About Dr Salim Janmohamed

GMC number: 3273850

Year qualified: 1988

Place of primary qualification: University of London

Dr Salim Janmohamed is a highly experienced Consultant Physician and Endocrinologist, specialising in Diabetes and General Medicine. He completed his medical training at University College Hospital London, earning a BSc in pharmacology and graduating with a triple distinction MBBS degree in 1988. Dr Janmohamed furthered his expertise with postgraduate training in London and Oxford, becoming a Member of the Royal College of Physicians in 1991. He has focused on Endocrinology and Diabetes since then, dedicating four years to research on pituitary disease and the genetics of diabetes and obesity.

Appointed as a Consultant in 1999, Dr Janmohamed practices at several London hospitals, including The Wellington and Royal Free Hospitals. He is a Fellow of the Royal College of Physicians and an Honorary Senior Lecturer at University College London. His specialist interests encompass metabolism, thyroid and parathyroid disease, pituitary and adrenal disorders, obesity, sex/reproductive hormones, osteoporosis, and hormonal treatments. He is also engaged in international clinical research on new and emerging medicines for cardiovascular and metabolic disorders.

Dr Janmohamed's clinical expertise includes general medical and endocrine investigations such as pituitary function tests, short synacthen tests, and thyroid biopsies.

He treats a wide range of conditions, including parathyroid disease, thyroid problems, Graves' disease, goitre, hyperthyroidism, hypothyroidism, thyroid nodules, Hashimoto's thyroiditis, diabetes, metabolic syndrome, pituitary disorders, hormone disorders, osteoporosis, polycystic ovary syndrome (PCOS), lipid disorders, menopause, prolactinoma, reproductive disorders, period problems, diabetes insipidus, adrenal disease, Addison's disease, and Cushing's syndrome.

Areas of expertise

  • Acromegaly or Gigantism
  • Adrenal Disease
  • Adrenocorticotropin Stimulation Tests (ACTH)
  • Blood Glucose Monitoring
  • Clinical Pharmacology
  • Diabetes & Endocrinology
  • Diabetes Insipidus
  • Diabetes
  • Disorders of Bone Metabolism
  • Endocrine Hypertension
  • Fine Needle Thyroid Biopsy
  • General (Internal) Medicine
  • General Medicine
  • Goitre
  • Hormone Disorders (Male)
  • Hormone Imbalances and Disorders (Female)
  • Hyperlipidaemia
  • Hypertension (High Blood Pressure)
  • Hyperthyroidism
  • Hypothyroidism
  • Metabolic Syndrome
  • Osteoporosis
  • Parathyroid Disease
  • Pituitary Disorders
  • Pituitary Function Test
  • Polycystic Ovary Syndrome (PCOS)
  • Prolactinoma
  • Reproductive Disorders
  • Thyroid Nodules
  • Thyroid Problems
  • Vitamin D Deficiency

Professional memberships

Royal College of Physicians
Royal Society of Medicine
General Medical Council
Endocrine Society (US)
American diabetes association

Articles by Dr Salim Janmohamed

Oral gepotidacin for the treatment of uncomplicated urogenital gonorrhoea (EAGLE-1): a phase 3 randomised, open-label, non-inferiority, multicentre study

Oral gepotidacin versus nitrofurantoin in patients with uncomplicated urinary tract infection (EAGLE-2 and EAGLE-3): two randomised, controlled, double-blind, double-dummy, phase 3, non-inferiority trials

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Sex and BMI Alter the Benefits and Risks of Sulfonylureas and Thiazolidinediones in Type 2 Diabetes: A Framework for Evaluating Stratification Using Routine Clinical and Individual Trial Data

The use of electronic health records for recruitment in clinical trials: a mixed methods analysis of the Harmony Outcomes Electronic Health Record Ancillary Study

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

New medicinal products for chronic heart failure: advances in clinical trial design and efficacy assessment.

Endocrinology of male sexual dysfunction

Electronic health records to facilitate clinical research

Improving clinical trials for cardiovascular diseases: a position paper from the Cardiovascular Round Table of the European Society of Cardiology

Relative bioavailability and the effect of meal type and timing on the pharmacokinetics of migalastat in healthy volunteers

EffectofDarapladibTreatmentonEndarterectomy CarotidPlaqueLipoprotein-AssociatedPhospholipaseA2 Activity:ARandomized,ControlledTrial

The pharmacological treatment of primary aldosteronism

Other specialists recommended by Dr Janmohamed